Skip to main content
logo
TRex Bio, Inc. (TRXB)
NASDAQ: TRXB · Real-Time Price · USD
15.49
+0.25 (1.64%)
At close: Oct 22, 2026, 4:00 PM EDT
15.50
+0.01 (0.06%)
After-hours: Oct 22, 2026, 7:30 PM EDT

TRex Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-46.39-34.81-3.14
Depreciation & Amortization
1.551.542.53
Loss (Gain) From Sale of Investments
-2.22-1.77-0.59
Stock-Based Compensation
0.610.450.25
Change in Accounts Payable
-0.46-0.16-0.59
Change in Unearned Revenue
---24.11
Change in Income Taxes
-0.04-0.080.28
Change in Other Net Operating Assets
0.71-6.54-0.2
Operating Cash Flow
-46.25-41.36-25.58
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Capital Expenditures
-0.06-0.07-0.07
Investment in Securities
-28.21-32.92-17.24
Investing Cash Flow
-28.26-32.99-17.3

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Issuance of Common Stock
0.280.30.05
Other Financing Activities
-0.68-0.01-0.47
Financing Cash Flow
49.642.0741.85

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Cash Flow
-24.91-32.28-1.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-46.31-41.43-25.65
Free Cash Flow Growth
---
Free Cash Flow Margin
---65.59%
Free Cash Flow Per Share
-10.46-10.22-6.66
Levered Free Cash Flow
--26.53-
Unlevered Free Cash Flow
--26.53-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash Income Tax Paid
0.1-2.49
Change in Working Capital
0.21-6.78-24.62
SEC Filings: 10-K · 10-Q